| ¿µ¹® | radiation dose | ÇÑ±Û | ¹æ»ç¼±·® |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±Á¶»çÀÇ Á¤µµ. ¹æ»ç¼±»ý¹°ÇÐÀ̳ª ÀÎüÀÇ ¹æ»ç¼±¹æÈ£¿¡¼´Â Àü¸®¹æ»ç¼±ÀÇ ¾ç, Áï ¼±·®ÀÌ ¹®Á¦°¡ µÈ´Ù. ¹æ»ç¼±·®¿¡¼µµ ±¹Á¦´ÜÀ§°è(SI)°¡ ä¿ëµÇ¾î ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)ÀÇ ±Ç°í¿¡ µû¶ó¼ ´ÙÀ½ÀÇ ¿©·¯ ´ÜÀ§°¡ ³Î¸® »ç¿ëµÈ´Ù. ¨ç Èí¼ö¼±·®(absorbed dose). ¹°ÁúÀÇ ´ÜÀ§Áú·®ÀÌ ¹æ»ç¼±¿¡ ÀÇÇØ ¹Þ¾ÆµéÀÌ´Â ¿¡³ÊÁö. ÀÌ ´ÜÀ§´Â ¹æ»ç¼± ¹× ¹°ÁúÀÇ Á¾·ù°¡ ¾î¶°ÇÑ °ÍÀÌ´õ¶óµµ »ç¿ëÇÒ ¼ö ÀÖ´Ù. ±¹Á¦´ÜÀ§´Â J/kgÀ̸ç À̰Ϳ¡ °íÀ¯ÇÑ ¸íĪÀ¸·Î ±×·¹ÀÌ(gray, ±âÈ£ Gy)°¡ ºÎ¿©µÈ´Ù. 1Gy=100¶óµå(rad). ¨è Á¶»ç¼±·®(exposure) ¶Ç´Â °øÁß¼±·®. X¼± ¶Ç´Â ¥ã¼±¿¡ ÇÑÇØ¼ »ç¿ëµÈ´Ù. ±¹Á¦´ÜÀ§´Â C/kg. ¨é ¼±·®´ç·®(dose equivalent). ¹æ»ç¼±¹æÈ£¸¦ À§ÇØ »ç¿ëµÇ´Â ¾ç. ±âÈ£´Â H. H´Â ¹æ»ç¼±ÀÇ Á¾·ù¿Í ¿¡³ÊÁö¿¡ ÀÇÇØ »ýü¿¡ ÁÖ´Â È¿°ú¸¦ º¸Á¤ÇÏ´Â ¼±Áú°è¼ö(Q)¿Í ±× ¹ÛÀÇ ÀÎÀÚ(¿¹¸¦ µé¸é ¼±·®·ü, ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ÀÇÇÑ ³»ºÎÇÇÆø½Ã¿¡´Â ±× ÇÙÁ¾ÀÇ Ã¼³»ºÐÆ÷ µî)¿¡ ±Ù°ÅÇÑ º¸Á¤°è¼ö(N)¸¦ Èí¼ö¼±·®(D)¿¡ °öÇÑ °Í, Áï H=D-Q-N. ¶ÇÇÑ DÀÇ ´ÜÀ§¸¦ Gy ¶Ç´Â rad·Î Ç¥½ÃÇÏ¿´À» ¶§ HÀÇ ´ÜÀ§¸¦ °¢°¢ ½Ãº£¸£Æ®(sievert, ±âÈ£ Sv) ¹× ·½(rem)À̶ó°í ÇÑ´Ù. µû¶ó¼ 1 Sv=102rem. ÀϹÝÀûÀ¸·Î ´ÜÀ§½Ã°£´çÀÇ ¼±·®À» ¼±·®·ü(dose rate)À̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | dose | ÇÑ±Û | ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·® |
|---|---|---|---|
| ¼³¸í | 1. ¾àÁ¦¸¦ ÇÑ ¹ø ¶Ç´Â ÇÏ·ç¿¡ »ç¿ëÇϰųª º¹¿ëÇÏ´Â ºÐ·®. 2. ¹°ÁúÀ̳ª Á¶Á÷¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ÀÛ¿ë Á¤µµ¸¦ ³ªÅ¸³»´Â ¾ç. Áï, ¹æ»ç¼±·®À̶ó´Â °³³äÀº ¾î¶² ÇÑ Á¡¿¡ ÀÔ»çÇÏ´Â ¹æ»ç¼±°ú ±× Á¡ ±Ùó¿¡ ÀÖ´Â ¹°Áú¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ¹°¸®Àû-ÈÇÐÀû-»ý¹°ÇÐÀû È¿°ú¿ÍÀÇ °ü°Ô¸¦ Á¤·®ÀûÀ¸·Î ³ªÅ¸³»´Â °øÅëÀΠôµµ·Î¼ »ý°¢µÈ °ÍÀÌ´Ù. ¶óµå(rad)·Î ³ªÅ¸³»´Â Èí¼ö·®, ·»Æ®°Õ(R)À¸·Î ³ªÅ¸³»´Â Á¶»ç ¼±·®, ·½(rem)À¸·Î ³ªÅ¸³»´Â ¼±·® ´ç·®À¸·Î ±¸ºÐÇÏ¿© ¾´´Ù. |
||
| ¿µ¹® | skin dose | ÇÑ±Û | ÇǺμ±·® |
|---|---|---|---|
| ¼³¸í | 1. ÇǺÎÇ¥¸é¿¡¼ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®. |
||
| ID | identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ... |
|---|---|
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| ED | early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff... |
| MED | median erythrocyte diameter; medical, medication, medicine; Medical Entities Dictionary; minimum eff... |
| MVV | 1) Maximal Voluntary Volume = MBV 2) Maximal V... |
| BED | Biologically Effective Dose |
|---|---|
| ED50 | Effective Dose |
| ED50 | Effective Dose 50 |
| EDE | Effective Dose Equivalent |
| MED | Minimal effective dose |
| maximal dose | <pharmacology> The largest amount of a drug or physical procedure that an adult can take with safety. (05 Mar 2000) |
|---|---|
| median effective dose | The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days. (05 Mar 2000) |
| effective dose | The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days. (05 Mar 2000) |
| maximal | The greatest possible, allowable or appreciable, the reverse of minimal. (18 Nov 1997) |
| maximal expiratory flow rate | <chest medicine, physiology> Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and fef 0.2-1.2. Acronym: MEFR (21 Jun 2000) |
| maximal expiratory flow-volume curve | <chest medicine> Curves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is mefv. (12 Dec 1998) |
| maximal Histalog test | A test for measurement of maximal production of gastric acidity or anacidity; it is similar to the histamine test, but uses Histalog (betazole hydrochloride), an analogue of histamine. Synonym: maximal Histalog test. (05 Mar 2000) |
| maximal midexpiratory flow rate | Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%. (12 Dec 1998) |
| maximal stimulus | A stimulus strong enough to evoke a maximal response. (05 Mar 2000) |
| maximal voluntary ventilation | Measure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are mvv and mbc. (12 Dec 1998) |
| point of maximal impulse | The point on the chest wall at which the maximal cardiac impulse is seen and/or felt. (05 Mar 2000) |
| aperture, effective | <microscopy> The diameter of the entrance pupil: it is the apparent diameter of the limiting aperture measured from the front. (05 Aug 1998) |
| renal blood flow, effective | The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood. (12 Dec 1998) |
| cost-effective | A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative. (05 Dec 1998) |
| effective | Producing the intended result. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|